References
- Reeder SB, Sirlin CB: Quantification of liver fat with magnetic resonance imaging. Magn Reson Imaging Clin N Am 2010; 18: 337–357, ix.
- Abd El-Kader SM, El-Den Ashmawy EM: Non-alcoholic fatty liver disease: The diagnosis and management. World J Hepatol 2015; 7: 846–858.
- Szczepaniak LS, Nurenberg P, Leonard D, Browning JD, Reingold JS, Grundy S et al.: Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 2005; 288: E462–E468.
- Lok AS, Everhart JE, Chung RT, Padmanabhan L, Greenson JK, Shiffman ML et al.: Hepatic steatosis in hepatitis C: comparison of diabetic and nondiabetic patients in the hepatitis C antiviral long-term treatment against cirrhosis trial. Clin Gastroenterol Hepatol 2007; 5: 245–254.
- Fartoux L, Chazouilleres O, Wendum D, Poupon R, Serfaty L: Impact of steatosis on progression of fibrosis in patients with mild hepatitis C. Hepatology 2005; 41: 82–87.
- Reeder SB, Cruite I, Hamilton G, Sirlin CB: Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy. J Magn Reson Imaging 2011; 34: 729–749.
- National Guideline Centre (UK): Non-alcoholic fatty liver disease: assessment and management. London: National Institute for Health and Care Excellence (UK) 2016; 6. Dostęp online: https://www.ncbi.nlm.nih.gov/books/NBK384715/.
- Regev A, Berho M, Jeffers LJ, Milikowski C, Molina EG, Pyrsopoulos NT et al.: Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002; 97: 2614–2618.
- Ratziu V, Charlotte F, Heurtier A, Gombert S, Giral P, Bruckert E et al.: Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 2005; 128: 1898–1906.
- Kinner S, Reeder SB, Yokoo T: Quantitative Imaging Biomarkers of NAFLD. Dig Dis Sci 2016; 61: 1337–1347.
- Noureddin M, Lam J, Peterson MR, Middleton M, Hamilton G, Le TA et al.: Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials. Hepatology 2013; 58: 1930–1940.
- Kang GH, Cruite I, Shiehmorteza M, Wolfson T, Gamst AC, Hamilton G et al.: Reproducibility of MRI-determined proton density fat fraction across two different MR scanner platforms. J Magn Reson Imaging 2011; 34: 928–934.
- Meisamy S, Hines CD, Hamilton G, Sirlin CB, McKenzie CA, Yu H et al.: Quantification of hepatic steatosis with T1-independent, T2-corrected MR imaging with spectral modeling of fat: blinded comparison with MR spectroscopy. Radiology 2011; 258: 767–775.
- Idilman IS, Aniktar H, Idilman R, Kabacam G, Savas B, Elhan A et al.: Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy. Radiology 2013; 267: 767–775.
- Rehm JL, Wolfgram PM, Hernando D, Eickhoff JC, Allen DB, Reeder SB: Proton density fat-fraction is an accurate biomarker of hepatic steatosis in adolescent girls and young women. Eur Radiol 2015; 25: 2921–2930.
- Permutt Z, Le TA, Peterson MR, Seki E, Brenner DA, Sirlin C et al.: Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease – MRI accurately quantifies hepatic steatosis in NAFLD. Aliment Pharmacol Ther 2012; 36: 22–29.
- Tang A, Tan J, Sun M, Hamilton G, Bydder M, Wolfson T et al.: Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis. Radiology 2013; 267: 422–431.
- Palmentieri B, de Sio I, La Mura V, Masarone M, Vecchione R, Bruno S et al.: The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis. Dig Liver Dis 2006; 38: 485–489.
- Osawa H, Mori Y: Sonographic diagnosis of fatty liver using a histogram technique that compares liver and renal cortical echo amplitudes. J Clin Ultrasound 1996; 24: 25–29.
- Webb M, Yeshua H, Zelber-Sagi S, Santo E, Brazowski E, Halpern Z et al.: Diagnostic value of a computerized hepatorenal index for sonographic quantification of liver steatosis. AJR Am J Roentgenol 2009; 192: 909–914.
- Mancini M, Prinster A, Annuzzi G, Liuzzi R, Giacco R, Medagli C et al.: Sonographic hepatic-renal ratio as indicator of hepatic steatosis: comparison with 1H magnetic resonance spectroscopy. Metabolism 2009; 58: 1724–1730.
- Marshall RH, Eissa M, Bluth EI, Gulotta PM, Davis NK: Hepatorenal index as an accurate, simple, and effective tool in screening for steatosis. AJR Am J Roentgenol 2012; 199: 997–1002.
- Borges VF, Diniz AL, Cotrim HP, Rocha HL, Andrade NB: Sonographic hepatorenal ratio: a noninvasive method to diagnose nonalcoholic steatosis. J Clin Ultrasound 2013; 41: 18–25.
- Martin-Rodriguez JL, Arrebola JP, Jimenez-Moleon JJ, Olea N, Gonzalez-Calvin JL: Sonographic quantification of a hepato-renal index for the assessment of hepatic steatosis in comparison with 3T proton magnetic resonance spectroscopy. Eur J Gastroenterol Hepatol 2014; 26: 88–94.
- Zhang B, Ding F, Chen T, Xia LH, Qian J, Lv GY: Ultrasound hepatic/renal ratio and hepatic attenuation rate for quantifying liver fat content. World J Gastroenterol 2014; 20: 17985–17992.
- Babu AS, Wells ML, Teytelboym OM, Mackey JE, Miller FH, Yeh BM et al.: Elastography in chronic liver disease: modalities, techniques, limitations, and future directions. Radiographics 2016; 36: 1987–2006.
- Middleton MS, Heba ER, Hooker CA, Bashir MR, Fowler KJ, Sandrasegaran K et al.: Agreement between magnetic resonance imaging proton density fat fraction measurements and pathologist-assigned steatosis grades of liver biopsies from adults with nonalcoholic steatohepatitis. Gastroenterology 2017; 153: 753–761.
- Kim M, Kang B-K, Jun DW: Comparison of conventional sonographic signs and magnetic resonance imaging proton density fat fraction for assessment of hepatic steatosis. Sci Rep 2018; 8: 7759.
- Shiralkar K, Johnson S, Bluth EI, Marshall RH, Dornelles A, Gulotta PM: Improved method for calculating hepatic steatosis using the hepatorenal index. J Ultrasound Med 2015; 34: 1051–1059.
- Loy M, Serra G, Chessa L: The prevalence of bright liver echo pattern in patients with chronic hepatitis C: correlation with steatosis and fibrosis. J Ultrasound 2014; 19: 91–98.
- Perez NE, Siddiqui FA, Mutchnick MG, Dhar R, Tobi M, Ullah N et al.: Ultrasound diagnosis of fatty liver in patients with chronic liver disease: a retrospective observational study. J Clin Gastroenterol 2007; 41: 624–629.
- Petta S, Maida M, Macaluso FS, Di Marco V, Cammà C, Cabibi D, Craxì A: The severity of steatosis influences liver stiffness measurement in patients with nonalcoholic fatty liver disease. Hepatology 2015; 62: 1101–1110.
- Samir AE, Dhyani M, Vij A, Bhan AK, Halpern EF, Méndez-Navarro J et al.: Shear-wave elastography for the estimation of liver fibrosis in chronic liver disease: determining accuracy and ideal site for measurement. Radiology 2015; 274: 888–896.